Peptide Associates Introduces Direct-Access GLP-3/Triple G Injection Program for Modern Wellness Consumers
Sarasota, Florida – 20 May 2026 – Peptide Associates today announced the launch of its Direct-Access GLP-3/Triple G Injection Program, a new initiative designed to support modern consumers seeking professionally guided metabolic wellness solutions through local clinical access points across the United States. The newly introduced program reflects the company’s ongoing commitment to combining advanced […] Continue Reading

